The global cardiovascular devices market size is anticipated to reach USD 86.36 billion by 2030 and is anticipated to expand at a CAGR of 8.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is significantly influenced by the increasing prevalence of cardiovascular diseases (CVDs) globally. As lifestyle changes and aging populations contribute to higher rates of conditions such as hypertension, heart attacks, and strokes, there is a growing demand for advanced medical technologies. Technological advancements in device design and functionality have led to improved patient outcomes, further driving market growth. The integration of minimally invasive techniques has also gained traction, appealing to both healthcare providers and patients seeking less traumatic treatment options.
Cardiovascular Disease (CVD) ranks among the top medical conditions globally. In May 2024, the CDC reported nearly 702,880 fatalities resulting from heart disease, representing 1 in every 5 deaths. Key factors propelling this market include rapid technological advancements, increased awareness & screening programs, and growth in demand for minimally invasive procedures.
Moreover, supportive government initiatives and funding aimed at enhancing healthcare infrastructure are propelling the market forward. Increased awareness regarding heart health among the general population has resulted in more individuals seeking preventive care and treatment options. Furthermore, the rise in healthcare expenditure across various regions is facilitating access to innovative cardiovascular devices, thereby expanding their adoption in clinical settings. In April 2024, MicroPort CRM introduced its new line of Implantable Cardiac Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)-ENERGYA and TALENTIA-in Europe. These devices feature Bluetooth connectivity.
Request a free sample copy or view report summary: Cardiovascular Devices Market Report
Based on product, surgical devices segment held largest revenue share of 68.8% in 2024 by product and is expected to grow at the highest CAGR over the forecast period due to their critical role in the cardiovascular device market, encompassing a wide range of products designed to diagnose, treat, and manage heart-related conditions.
The diagnostic & monitoring segment is expected to grow at the fastest CAGR over the forecast period owing to technological advancements, such as miniaturization and integration of AI in diagnostic tools, which can improve accuracy & patient outcomes.
Based on region, North America dominated the segment by region with a market share of 47.7% in 2024 due to an advanced healthcare infrastructure, high prevalence of CVDs, and significant R&D investments by regional players.
Asia Pacific segment is expected to grow at the fastest CAGR over the forecast period owing to rising healthcare expenditures and government initiatives to improve healthcare infrastructure
Grand View Research has segmented global cardiovascular devices market on the basis of product and region:
Cardiovascular Devices Product Outlook (Revenue, USD Million, 2018 - 2030)
Diagnostic & Monitoring Devices
ECG
Implantable Cardiac Monitors
Holter Monitors
Mobile Cardiac Telemetry
MRI
Cardiovascular Ultrasound
2D
3D/4D
Doppler
Cardiac Diagnostic Catheters
PET Scanner
Surgical Devices
Cardiac Resynchronization Therapy (CRT)
CRT-Defibrillator
CRT-Pacemaker
Implantable Cardioverter Defibrillators (ICDs)
Single Chamber ICDs
Dual Chamber ICDs
Pacemakers
Conventional Pacemakers
Leadless Pacemakers
Coronary Stents
Catheters
Guidewires
Cannula
Valves
Occlusion Devices
Cardiovascular Devices Regional Outlook (Revenue in USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Mexico
Middle East and Africa
Saudi Arabia
South Africa
UAE
Kuwait
List of Key Companies in the Cardiovascular Devices Market
Abbott
GE HealthCare
Edwards Lifesciences Corporation
W. L. Gore & Associates, Inc.
Siemens Healthcare GmbH
BIOTRONIK SE & Co. KG
Canon Medical Systems Asia Pte. Ltd.
B. Braun SE
LivaNova PLC
Cardinal Health
Medtronic
Boston Scientific Corporation
"The quality of research they have done for us has been excellent..."